We therefore propose that this mechanism of αvβ3-regulated, LC3-directed trafficking helps to maintain the balance between rapid production of broad specificity, low affinity antibodies from MZ and B-1 B cells early in infections while preventing potential development of high affinity autoantibodies. The gene discussed is MAP1LC3A; the disease is infection.